rs-hemojuvelin (UCLA)

N/A

Report date: 2025/03/19 11:40:32

Base Information

Drug Namers-hemojuvelin (UCLA)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant proteinDiagnostic agent (In vivo)
Mechanisms of ActionHemochromatosis type 2 protein stimulants
TargetsHemochromatosis type 2 protein
Therapy Area/IndicationsIron Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California, Los Angeles
Inactive CompaniesN/A
Active IndicationsIron Metabolism Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A